Wondering why cannabis is considered a Schedule I drug by the DEA and what efforts are being made to reschedule it? Or how the increased legalization and use of cannabis for medicinal purposes has paved the path for other drugs with potentially therapeutic qualities? What about how wholesalers, retailers, and consumers complete monetary transactions for a federally illegal substance in this age of digital banking?
If these are top of mind in your practice, then the 2023 DRI Cannabis Seminar is the place to be! Join us in New Orleans to listen to thought leaders from across the industry – from businesses to bankers to scientists to lawyers to insurers – as they present on exciting subjects such as recent efforts to research and reschedule cannabis; privacy concerns for businesses and consumers engaged in cannabis transactions; fintech infrastructure specific to cannabis transactions; insurance concerns facing those involved in the cannabis industry; cannabis toxicology; and evolving rules and regulations of psychedelic and psychedelic-adjacent drugs in light of success with medicinal cannabis. Plus, don’t miss the cross-seminar presentation with the DRI Employment Law Seminar on the state of cannabis in the workplace.